ArticleFrontiers in pharmacology2025

Microbiota and metabolomic profiling coupled with machine learning to identify biomarkers and drug targets in nasopharyngeal carcinoma.

Junsong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.